20-63929545-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_025219.3(DNAJC5):​c.321+20C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0357 in 1,457,746 control chromosomes in the GnomAD database, including 2,347 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.079 ( 539 hom., cov: 31)
Exomes 𝑓: 0.031 ( 1808 hom. )

Consequence

DNAJC5
NM_025219.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.15

Publications

3 publications found
Variant links:
Genes affected
DNAJC5 (HGNC:16235): (DnaJ heat shock protein family (Hsp40) member C5) This gene is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. A pseudogene of this gene is located on the short arm of chromosome 8. [provided by RefSeq, Nov 2010]
DNAJC5 Gene-Disease associations (from GenCC):
  • ceroid lipofuscinosis, neuronal, 4 (Kufs type)
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
  • adult neuronal ceroid lipofuscinosis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 20-63929545-C-T is Benign according to our data. Variant chr20-63929545-C-T is described in ClinVar as Benign. ClinVar VariationId is 137123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAJC5NM_025219.3 linkc.321+20C>T intron_variant Intron 3 of 4 ENST00000360864.9 NP_079495.1 Q9H3Z4-1Q6AHX3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAJC5ENST00000360864.9 linkc.321+20C>T intron_variant Intron 3 of 4 1 NM_025219.3 ENSP00000354111.4 Q9H3Z4-1
DNAJC5ENST00000470551.1 linkn.321+20C>T intron_variant Intron 3 of 5 2 ENSP00000434744.1 Q9H3Z4-2
DNAJC5ENST00000703637.1 linkn.321+20C>T intron_variant Intron 3 of 5 ENSP00000515413.1 Q9H3Z4-2

Frequencies

GnomAD3 genomes
AF:
0.0791
AC:
11932
AN:
150812
Hom.:
539
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0783
Gnomad AMI
AF:
0.177
Gnomad AMR
AF:
0.0726
Gnomad ASJ
AF:
0.0685
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.0644
Gnomad FIN
AF:
0.0814
Gnomad MID
AF:
0.104
Gnomad NFE
AF:
0.0770
Gnomad OTH
AF:
0.0849
GnomAD2 exomes
AF:
0.0298
AC:
6524
AN:
219044
AF XY:
0.0268
show subpopulations
Gnomad AFR exome
AF:
0.0351
Gnomad AMR exome
AF:
0.0294
Gnomad ASJ exome
AF:
0.0146
Gnomad EAS exome
AF:
0.0731
Gnomad FIN exome
AF:
0.0434
Gnomad NFE exome
AF:
0.0244
Gnomad OTH exome
AF:
0.0326
GnomAD4 exome
AF:
0.0307
AC:
40104
AN:
1306826
Hom.:
1808
Cov.:
32
AF XY:
0.0329
AC XY:
21478
AN XY:
653214
show subpopulations
African (AFR)
AF:
0.0329
AC:
991
AN:
30112
American (AMR)
AF:
0.0382
AC:
1545
AN:
40436
Ashkenazi Jewish (ASJ)
AF:
0.0427
AC:
1035
AN:
24252
East Asian (EAS)
AF:
0.101
AC:
3800
AN:
37596
South Asian (SAS)
AF:
0.0422
AC:
3383
AN:
80188
European-Finnish (FIN)
AF:
0.0738
AC:
3734
AN:
50618
Middle Eastern (MID)
AF:
0.0588
AC:
308
AN:
5236
European-Non Finnish (NFE)
AF:
0.0233
AC:
22942
AN:
983368
Other (OTH)
AF:
0.0430
AC:
2366
AN:
55020
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
2454
4909
7363
9818
12272
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0791
AC:
11936
AN:
150920
Hom.:
539
Cov.:
31
AF XY:
0.0779
AC XY:
5749
AN XY:
73786
show subpopulations
African (AFR)
AF:
0.0782
AC:
3214
AN:
41074
American (AMR)
AF:
0.0726
AC:
1103
AN:
15192
Ashkenazi Jewish (ASJ)
AF:
0.0685
AC:
236
AN:
3446
East Asian (EAS)
AF:
0.128
AC:
653
AN:
5082
South Asian (SAS)
AF:
0.0643
AC:
307
AN:
4776
European-Finnish (FIN)
AF:
0.0814
AC:
855
AN:
10498
Middle Eastern (MID)
AF:
0.105
AC:
31
AN:
294
European-Non Finnish (NFE)
AF:
0.0770
AC:
5201
AN:
67550
Other (OTH)
AF:
0.0836
AC:
176
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
538
1077
1615
2154
2692
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0496
Hom.:
50
Bravo
AF:
0.0836
Asia WGS
AF:
0.0530
AC:
180
AN:
3380

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Dec 02, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 04, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Neuronal ceroid lipofuscinosis Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.97
DANN
Benign
0.73
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295436; hg19: chr20-62560898; API